Le mode conseil est activé Arrêter

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout
 
(%)
US78464A8707
XBI ISIN
Fonds négociés en bourse (FNB)
Type de fonds
SPDR State Street Global Advisors
Fournisseur
136,35 USD
valeur liquidative par action | 15/06/2026
31/01/2006
Date de lancement
4 fois par an
Paiement de dividendes
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Objet d'investissement
Biotech
Secteur
USA
Géographie
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Ratio de coût total
8.507,96 mln USD
Actif total du fonds | 15/06/2026
8.507,96 mln USD
Volume des actits de classe "actions" | 15/06/2026
Non
UCITS
1 / 3 (11/09/2015)
Split

Rendement au 15/06/2026, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1Y
    62,15 %
  • 3Y
    51,47 %
  • 5Y
    0,91 %
  • 10Y
    143,19 %
Au prix de la bourse, avec prise en compte des paiements

Dernières données pour
Ajouter à comparer
de
au
ADD-IN
Add-in Cbonds API
bond data api

Cotations (XBI)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

167 970

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

  • Screener d'obligations
  • liste de surveillance
  • Excel ADD-IN
Obtenir l'accès

Dynamique des prix

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI au 12/06/2026

Exporter la structure dans Excel
Titre Valeur
TRAVERE THERAPEUTICS INC 2,06%
TG THERAPEUTICS INC 2,03%
TWIST BIOSCIENCE CORP 1,95%
REVOLUTION MEDICINES INC 1,82%
ALKERMES PLC 1,81%
ARROWHEAD PHARMACEUTICALS IN 1,5%
KRYSTAL BIOTECH INC 1,44%
EXELIXIS INC 1,44%
NUVALENT INC A 1,4%
NEUROCRINE BIOSCIENCES INC 1,39%
BEAM THERAPEUTICS INC 1,35%
PTC THERAPEUTICS INC 1,32%
PROTAGONIST THERAPEUTICS INC 1,32%
MADRIGAL PHARMACEUTICALS INC 1,31%
APOGEE THERAPEUTICS INC 1,31%
VERACYTE INC 1,29%
CYTOKINETICS INC 1,27%
NATERA INC 1,25%
MIRUM PHARMACEUTICALS INC 1,25%
INCYTE CORP 1,22%
HALOZYME THERAPEUTICS INC 1,21%
SCHOLAR ROCK HOLDING CORP 1,2%
SPYRE THERAPEUTICS INC 1,19%
CRISPR THERAPEUTICS AG 1,19%
KYMERA THERAPEUTICS INC 1,19%
BIOGEN INC 1,18%
ARCUTIS BIOTHERAPEUTICS INC 1,18%
ROIVANT SCIENCES LTD 1,15%
IMMUNOVANT INC 1,15%
UNITED THERAPEUTICS CORP 1,14%
RHYTHM PHARMACEUTICALS INC 1,13%
IONIS PHARMACEUTICALS INC 1,12%
ABBVIE INC 1,1%
BRIDGEBIO PHARMA INC 1,08%
MODERNA INC 1,05%
ULTRAGENYX PHARMACEUTICAL IN 1,05%
AMGEN INC 1,05%
BIOMARIN PHARMACEUTICAL INC 1,04%
COGENT BIOSCIENCES INC 1,04%
VERTEX PHARMACEUTICALS INC 1,04%
ALNYLAM PHARMACEUTICALS INC 1,02%
CG ONCOLOGY INC 1,02%
PRAXIS PRECISION MEDICINES I 1,01%
IMMUNITYBIO INC 0,98%
VAXCYTE INC 0,98%
ACADIA PHARMACEUTICALS INC 0,97%
GILEAD SCIENCES INC 0,97%
CATALYST PHARMACEUTICALS INC 0,95%
DISC MEDICINE INC 0,95%
VIKING THERAPEUTICS INC 0,94%
SUMMIT THERAPEUTICS INC 0,92%
ERASCA INC 0,91%
REGENERON PHARMACEUTICALS 0,9%
VERA THERAPEUTICS INC 0,87%
TANGO THERAPEUTICS INC 0,87%
CELCUITY INC 0,86%
DYNE THERAPEUTICS INC 0,86%
DENALI THERAPEUTICS INC 0,84%
GRAIL INC 0,83%
AGIOS PHARMACEUTICALS INC 0,82%
BIOCRYST PHARMACEUTICALS INC 0,81%
INSMED INC 0,79%
INTELLIA THERAPEUTICS INC 0,75%
RECURSION PHARMACEUTICALS A 0,74%
IMMUNOME INC 0,71%
ORUKA THERAPEUTICS INC 0,7%
ARCUS BIOSCIENCES INC 0,7%
IDEAYA BIOSCIENCES INC 0,66%
DIANTHUS THERAPEUTICS INC 0,65%
SAREPTA THERAPEUTICS INC 0,64%
NURIX THERAPEUTICS INC 0,64%
UNIQURE NV 0,63%
BIOHAVEN LTD 0,62%
KODIAK SCIENCES INC 0,61%
ARDELYX INC 0,58%
MANNKIND CORP 0,58%
VIRIDIAN THERAPEUTICS INC 0,58%
SYNDAX PHARMACEUTICALS INC 0,58%
NOVAVAX INC 0,57%
VERICEL CORP 0,57%
MINERALYS THERAPEUTICS INC 0,57%
RELAY THERAPEUTICS INC 0,56%
ADMA BIOLOGICS INC 0,56%
CELLDEX THERAPEUTICS INC 0,52%
SELLAS LIFE SCIENCES GROUP I 0,48%
CAREDX INC 0,47%
MONTE ROSA THERAPEUTICS INC 0,47%
STOKE THERAPEUTICS INC 0,45%
TAYSHA GENE THERAPIES INC 0,45%
ABSCI CORP 0,44%
IOVANCE BIOTHERAPEUTICS INC 0,44%
PALVELLA THERAPEUTICS INC 0,43%
CAPRICOR THERAPEUTICS INC 0,42%
ANAPTYSBIO INC 0,41%
PRECIGEN INC 0,38%
INHIBRX BIOSCIENCES INC 0,37%
CORVUS PHARMACEUTICALS INC 0,34%
OLEMA PHARMACEUTICALS INC 0,33%
KURA ONCOLOGY INC 0,32%
RIGEL PHARMACEUTICALS INC 0,32%
Montrer tout Cacher
Autres - %

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Valeur nette d'actifs
    {{ item.expense_ratio }}
    Ratio de coût total
Vous devez vous inscrire pour y accéder.